17th September 2021 | Pharma Updates
NCLT Ahmedabad sanctions consolidation of Sun Pharma Global FZE with Sun Pharmaceutical Industries
The organization will document the certified order of the National Company Law Tribunal Ahmedabad with the Registrar of Companies, Ahmedabad, Gujarat.
Rupifi, Retailio Deal Gives India Drug SMBs BNPL Options
The Indian lending FinTech Rupifi has collaborated with Retailio to enable credit for its pharma retailers.
India must Reposition its Drug Sector
India manufactures drugs for a range of diseases like malaria, cancer, asthma, HIV, heart diseases, etc.
NCLT approves merger of Lincoln Parenteral & Lincoln Pharmaceuticals
Consolidation of Lincoln Parenteral and Lincoln Pharma is expected to bring lots of synergies in terms of cost-effectiveness, efficiency, competitive strength, and productivity for the combined entity, Lincoln Pharmaceuticals said.
Biological E gets nod to manufacture J&J Covid vaccine in India
As indicated by the sources, conversations are on among J&J and the Centre on the issue of reimbursement against any serious side effects after vaccination.
ADQ buys Swiss pharma company Acino
The deal is the Abu Dhabi organization’s largest within the healthcare and drug sector.
Russia urges India to lift the restriction on the export of Sputnik Light
The Sputnik Light antibody in India is delivered by Hetero Biopharma which is one of the Russian Direct Investment Fund partners in the production of the Covid vaccine.